{"prompt": "['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', '2 = moderate', '2 = moderate', '2 = moderate', '1 = >0 - < 10%', '3 = severe', '3 = severe', '3 = severe', '2 = 10 - <30%', '4 = very severe', '4 = very severe', '4 = very severe', '3 = 30 - <50%', '4 = 50 - <70%', '5 = 70 - <90%', '6 = 90 - 100%', 'The PPPASI score is calculated using the formula:', 'PPPASI = 0.2 (ERP + PRP + DRP) ARP + 0.2 (ELP + PLP + DLP) ALP + 0.3 (ERS + PRS +', 'DRS) ARS + 0.3 (ELS + PLS + DLS) ALS', '(36)', 'Page 71 of 75']['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', \"21.4 Appendix IV - Physician's Global Assessment (PGA)\", 'To be assessed by the investigator:', 'Assessment of the average severity of all skin lesions at the assessment timepoint according to the', 'following categories:', 'Score', 'Category', 'Description', 'Plaque elevation = 0 (no elevation over normal skin)', '0', 'Clear', 'Scaling = 0 (no evidence of scaling)', 'Erythema = 0 (except for residual hyperpigmentation/', 'hypopigmentation)', 'Plaque elevation = I (possible but difficult to ascertain whether', 'there is a slight elevation above normal skin)', '1', 'Almost Clear', 'Scaling = (surface dryness with some desquamation)', 'Erythema = 1 (faint, diffuse pink or slight red coloration)', 'Plaque elevation = slight (slight but definite elevation, typically', 'edges are indistinct or sloped)', '2', 'Mild', 'Scaling = fine (fine scale partially or mostly covering lesions)', 'Erythema = mild (light red coloration)', 'Plaque elevation = marked (marked definite elevation with rough', 'or sloped edges)', '3', 'Moderate', 'Scaling = coarser (coarser scale covering most or all of the', 'lesions)', 'Erythema = moderate (definite red coloration)', 'Plaque elevation = marked (marked elevation typically with hard', 'or sharp edges)', '4', 'Severe', 'Scaling = coarser (coarse, non tenacious scale predominates', 'covering most or all of the lesions)', 'Erythema = severe (very bright red coloration)', 'Adapted from (37)', 'Page 72 of 75']['Confidential', 'Prof. Dr. Kristian Reich', 'Clinical Study Protocol', 'APLANTUS 069-008', 'Final 3.0, 07. June 2018', '21.5 Appendix V - Dynamic Hand and Feet (H&F) PGA', 'To be assesses by the investigator:', 'Assessment of the global improvement of the H&F Psoriasis lesions compared from baseline to the', 'assessment timepoint, reflecting a global consideration of at least erythema, scaling, plaque thickness,', 'fissuring and postulation according to the following categories:', 'Category', 'Percentage', 'Category Description', 'Improvement', 'Cleared (0)', '100%', 'Remission of all clinical signs and symptoms as', 'compared with baseline, except for residual', 'manifestations such as mild erythema', 'Excellent (1)', '75% 99%', 'Improvement of all clinical signs and symptoms as', 'compared with baseline, except for residual', 'manifestations such as mild erythema', 'Good (2)', '50% - 74%', 'Improvement of all clinical signs and symptoms as', 'compared with baseline', 'Fair (3)', '25% 49%', 'Improvement of all clinical signs and symptoms as', 'compared with baseline', 'Slight (4)', '1% 24%', 'Improvement of all clinical signs and symptoms as', 'compared with baseline', 'Unchanged (5)', 'Clinical signs and symptoms unchanged from', 'baseline', 'Worse (6)', 'Clinical signs and symptoms deteriorated from', 'baseline', '(38)', 'Page 73 of 75']\n\n###\n\n", "completion": "END"}